Yasin Keshvargar
Lawyers
Filters
Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Beam Therapeutics $300 million at-the-market offering
We advised the sales agent in connection with the equity offering
LAVA Therapeutics $100.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Gyroscope Therapeutics $148.0 million Series C equity financing
We advised Gyroscope Therapeutics on its private placement of preferred stock
loanDepot $600 million senior notes offering
We advised the initial purchasers on the high-yield debt offering
Solid Biosciences $143.75 million follow-on equity offering
We advised the joint book-running managers on the stock offering
European Biotech Acquisition $120 million IPO
We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Shake Shack $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering